Understanding Hemorrhagic Shock: Biomarkers and Treatments
Author Information
Author(s): Meza Monge Kenneth, Rosa Caleb, Sublette Christopher, Pratap Akshay, Kovacs Elizabeth J., Idrovo Juan-Pablo
Primary Institution: University of Colorado, Aurora, CO, USA
Hypothesis
What are the effective biomarkers and therapeutic strategies for managing hemorrhagic shock?
Conclusion
The review highlights the importance of early hemorrhage control and tailored therapeutic approaches to improve outcomes in hemorrhagic shock.
Supporting Evidence
- Hemorrhagic shock accounts for 30-40% of trauma-related deaths worldwide.
- Early hemorrhage control and appropriate blood product ratios improve outcomes.
- Inflammatory responses evolve through distinct phases, impacting treatment strategies.
- Current evidence supports the use of tranexamic acid in early intervention.
Takeaway
Hemorrhagic shock is a serious condition that can be treated better with the right tests and timely medical help.
Methodology
This is a comprehensive review examining the pathophysiology, biomarkers, and therapeutic interventions for hemorrhagic shock.
Limitations
Many molecular targeted therapies remain investigational and require further validation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website